What is Synutra International Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Synutra International's interest expense for the
three
months ended in Dec. 2016 was $ -3.6 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Dec. 2016 was $-14.3 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Synutra International's Operating Income for the
three
months ended in Dec. 2016 was $ 6.9 Mil. Synutra International's Interest Expense for the
three
months ended in Dec. 2016 was $ -3.6 Mil.
Synutra International's Interest Coverage for the quarter that ended in Dec. 2016 was 1.92.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Synutra International Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synutra International (NAS:SYUT) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Synutra International's Interest Expense for the
three
months ended in Dec. 2016 was $-3.6 Mil. Its
Operating Income
for the
three
months ended in Dec. 2016 was $6.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Dec. 2016 was $278.3 Mil.
Synutra International's Interest Coverage for the quarter that ended in Dec. 2016 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Synutra International (Synutra International) Business Description
Traded in Other Exchanges
N/A
Address
Synutra International Inc was formed on October 30, 1998. The Company is engaged in the production, distribution & sales of dairy based nutritional products under Shengyuan or Synutra line of brands in China. Its other nutritional product includes prepared foods, nutritional ingredients & supplements. It is focused on selling powdered formula products for infants and adults, and is also engaged in other nutritional product offerings, such as prepared foods and certain nutritional supplements. It sells the products through an extensive nationwide sales and distribution network covering all provinces and provincial-level municipalities in mainland China. It has three reportable segments; nutritional food, nutritional supplement and other business. The Nutritional Food segment includes the sale of powdered infant and adult formula products, with brands including Super, My Angel and Dutch Cow, as well as the sale of prepared foods under the Huiliduo brand; Nutritional Supplement: includes the production and sale of nutritional supplements such as chondroitin sulfate to third parties, and microencapsulated Docosahexanoic Acid ("DHA") and Arachidonic Acid ("ARA") to the nutritional food segment for use in powdered formula production; and Other Business includes non-core businesses such as ancillary sales of excess or unusable ingredients and materials to industrial customers, providing genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women. Its business requires certain key raw materials, such as milk powder and whey powder. The Company competes with both multinational and domestic infant formula producers.
Executives
| Warburg Pincus & Co. |
10 percent owner |
450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147 |
| Warburg Pincus Llc |
10 percent owner |
450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Warburg Pincus Partners Llc |
10 percent owner |
450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Joseph P. Landy |
10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Charles R Kaye |
10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Warburg Pincus Private Equity Ix, L.p. |
10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Warburg Pincus Ix Llc |
10 percent owner |
450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| David Hui Li |
director |
C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 |
Synutra International (Synutra International) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SYUT has been successfully added to your 